Luye Pharma's Global Strategy For CNS-Focused Products Gathers...
SHANGHAI, Dec. 12, 2018 /PRNewswire-AsiaNet/ -- Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003) for the treatment of Parkinson's disease has been submitted to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan...
Read more https://view-release/?pr-id=76733